Anticancer Research, In Vivo, Cancer Genomics & Proteomics, and Cancer Diagnosis & Prognosis are independent international journals, published by the International Institute of Anticancer Research (IIAR), and have had no relation or association with other publishers since their establishment.

At the IIAR, we are committed to maintaining the highest content quality and the most rapid processing of submitted articles to our four journals.

All submitted articles are peer-reviewed to secure a valid assessment. Our preliminary review for all cited references includes a thorough plagiarism screening as well as a detailed assessment of the conclusions’ suitability and validity. 

We value the support of our policy by our Authors and Readers and we look forward to receiving comments and suggestions for the continuous improvement of our services.